PetMed Express Files 8-K on Financials

TL;DR

PETS filed an 8-K, check the financials for the latest on operations.

AI Summary

On August 6, 2024, PetMed Express, Inc. filed an 8-K report. The filing primarily concerns the company's financial condition and results of operations, with specific details expected to be found within the accompanying financial statements and exhibits.

Why It Matters

This filing provides investors with crucial updates on PetMed Express's financial performance and operational status, which can influence investment decisions.

Risk Assessment

Risk Level: low — This is a routine financial filing and does not appear to contain any immediate negative news or significant changes.

Key Numbers

• 000-28827 — SEC File Number (Identifies the company's filing history with the SEC.)
• 65-0680967 — IRS Number (Company's Employer Identification Number.)

Key Players & Entities

• PETMED EXPRESS INC (company) — Registrant
• August 6, 2024 (date) — Date of report
• Florida (location) — State of incorporation
• 420 South Congress Avenue, Delray Beach, Florida 33445 (address) — Principal executive offices

FAQ

Filing Documents

• pets-20240806.htm (8-K) — 28KB
• pets-20240630xexx991.htm (EX-99.1) — 168KB
• 0001040130-24-000065.txt ( ) — 332KB
• pets-20240806.xsd (EX-101.SCH) — 2KB
• pets-20240806_lab.xml (EX-101.LAB) — 21KB
• pets-20240806_pre.xml (EX-101.PRE) — 12KB
• pets-20240806_htm.xml (XML) — 3KB

02 Results of Operations and Financial Condition

Item 2.02 Results of Operations and Financial Condition. On August 6, 2024, PetMed Express, Inc. (the "Company") issued a press release announcing its June 30, 2024 first quarter of fiscal year 2025 financial results and other financial information, and that management would review these results in a conference call at 4:30 pm Eastern time on August 6, 2024. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. The information in this Item 2.02 and the information contained in Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended ("Exchange Act"), or otherwise subject to the liabilities of that section, and shall not be deemed incorporated by reference in any Company filing under the Securities Act of 1933, as amended ("Securities Act"), or the Exchange Act, whether made before or after the date hereof and regardless of any general incorporation language in such filings, except as shall be expressly set forth by specific reference in such filing. The Company is making reference to non-GAAP financial information in both the press release and the conference call. A reconciliation of these non-GAAP financial measures to the nearest comparable GAAP financial measures is contained in the attached press release.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. 99.1 – Press release dated August 6, 2024. 104 – Cover Page Interactive Data File (formatted as Inline XBRL). EXHIBIT INDEX Exhibit No. Description 99.1 Press release dated August 6, 2024 104 Cover Page Interactive Data File (formatted as Inline XBRL) 2

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: August 6, 2024 PETMED EXPRESS, INC. By: /s/ Sandra Y. Campos Name: Sandra Y. Campos Title: Chief Executive Officer and President 3

View Full Filing

View this 8-K filing on SEC EDGAR